Literature DB >> 4534021

Incidence of eye disease in cases of connective tissue disease.

J Williamson.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4534021

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN： 0078-5334


× No keyword cloud information.
  8 in total

1.  Angle-closure glaucoma secondary to posterior scleritis.

Authors:  M P Quinlan; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

Review 2.  Inflammatory conditions of the eye associated with rheumatic diseases.

Authors:  N A Afshari; M A Afshari; C S Foster
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

3.  Scleritis and episcleritis.

Authors:  P G Watson; S S Hayreh
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

4.  External ocular findings in lupus erythematosus: a clinical and immunopathological study.

Authors:  P Frith; S M Burge; P R Millard; F Wojnarowska
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

5.  Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study.

Authors:  Gelareh Homayounfar; Natalie Nardone; Durga S Borkar; Vivien M Tham; Travis C Porco; Wayne T A Enanoria; John V Parker; Aleli C Vinoya; Aileen Uchida; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2013-07-24       Impact factor: 5.258

6.  Steroid responsiveness in connective tissue diseases.

Authors:  H Gaston; M J Absolon; O A Thurtle; M A Sattar
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

Review 7.  The impact of new methods of investigation and treatment on the understanding of the pathology of scleral inflammation.

Authors:  P Watson; A Romano
Journal:  Eye (Lond)       Date:  2014-05-30       Impact factor: 3.775

8.  Inflammation after cataract extraction and intraocular lens implantation in patients with rheumatoid arthritis.

Authors:  T Matsuo; M Fujiwara; N Matsuo
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.